Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,755 | 1,346 | 99.8% |
| Education | $33.24 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,878 | 262 | $0 (2024) |
| ABBVIE INC. | $1,794 | 134 | $0 (2024) |
| Lilly USA, LLC | $1,446 | 90 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,277 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $937.74 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $910.10 | 66 | $0 (2022) |
| Allergan, Inc. | $871.15 | 124 | $0 (2020) |
| Amgen Inc. | $829.70 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $724.22 | 44 | $0 (2024) |
| Amarin Pharma Inc. | $609.51 | 42 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,284 | 123 | Novo Nordisk Inc ($537.04) |
| 2023 | $2,370 | 140 | AbbVie Inc. ($436.67) |
| 2022 | $2,343 | 168 | ABBVIE INC. ($408.04) |
| 2021 | $2,357 | 167 | AbbVie Inc. ($402.28) |
| 2020 | $1,714 | 120 | Novo Nordisk Inc ($315.96) |
| 2019 | $2,323 | 194 | Novo Nordisk Inc ($355.17) |
| 2018 | $2,362 | 198 | Novo Nordisk Inc ($389.48) |
| 2017 | $3,034 | 241 | Allergan Inc. ($371.14) |
All Payment Transactions
1,351 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: VACCINE | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Biological | ||||||
| 12/02/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Biological | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: VACCINE | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Biological | ||||||
| 10/30/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,560 | 2,786 | $245,931 | $128,982 |
| 2022 | 18 | 1,687 | 3,015 | $269,678 | $136,439 |
| 2021 | 26 | 1,721 | 3,050 | $270,766 | $136,216 |
| 2020 | 20 | 1,730 | 3,091 | $282,754 | $127,840 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 461 | $69,150 | $33,092 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 319 | 502 | $60,240 | $27,329 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 161 | 161 | $24,150 | $19,115 | 79.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 67 | 222 | $21,090 | $11,444 | 54.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 188 | $14,100 | $7,687 | 54.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 43 | 45 | $11,250 | $6,086 | 54.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 257 | 631 | $7,572 | $5,239 | 69.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 31 | 36 | $9,000 | $5,042 | 56.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 72 | 72 | $5,400 | $5,035 | 93.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 78 | $2,730 | $2,254 | 82.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 49 | 56 | $4,200 | $1,939 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 49 | 112 | $5,264 | $1,817 | 34.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 19 | 20 | $2,500 | $1,528 | 61.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 57 | $1,995 | $488.02 | 24.5% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 14 | 14 | $2,380 | $321.96 | 13.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 54 | 73 | $2,190 | $248.93 | 11.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 21 | 21 | $2,100 | $244.12 | 11.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 13 | 13 | $260.00 | $49.25 | 18.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 24 | $360.00 | $23.10 | 6.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 271 | 496 | $74,400 | $34,616 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 322 | 544 | $65,310 | $30,406 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 162 | 162 | $24,415 | $19,657 | 80.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 31 | 296 | $22,200 | $12,154 | 54.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 69 | 207 | $19,665 | $10,403 | 52.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 43 | 47 | $11,750 | $7,108 | 60.5% |
About Dr. Joshua Bradford, DO
Dr. Joshua Bradford, DO is a Family Medicine healthcare provider based in South Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689899510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Bradford, DO has received a total of $18,789 in payments from pharmaceutical and medical device companies, with $2,284 received in 2024. These payments were reported across 1,351 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($18,755).
As a Medicare-enrolled provider, Bradford has provided services to 6,698 Medicare beneficiaries, totaling 11,942 services with total Medicare billing of $529,476. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location South Charleston, WV
- Active Since 04/16/2007
- Last Updated 11/16/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689899510
Products in Payments
- Ozempic (Drug) $1,153
- XARELTO (Drug) $772.33
- FARXIGA (Drug) $707.48
- UBRELVY (Drug) $639.90
- VRAYLAR (Drug) $638.36
- Vascepa (Drug) $609.51
- ENTRESTO (Drug) $563.20
- XIFAXAN (Drug) $490.65
- TRADJENTA (Drug) $481.87
- TRULICITY (Drug) $464.05
- JARDIANCE (Drug) $454.75
- LINZESS (Drug) $451.41
- ELIQUIS (Drug) $381.58
- Victoza (Drug) $373.35
- EVENITY (Biological) $368.66
- Rybelsus (Drug) $358.54
- MOUNJARO (Drug) $355.06
- QULIPTA (Drug) $353.04
- Kerendia (Drug) $316.89
- VIBERZI (Drug) $285.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Charleston
Dr. Julie Detemple, Md, MD
Family Medicine — Payments: $92,852
Dr. Rohit Patel, M.d, M.D
Family Medicine — Payments: $26,815
Michelle Burdette, Md, Retired, MD, RETIRED
Family Medicine — Payments: $12,269
Dr. Chad Turner, Md, MD
Family Medicine — Payments: $10,522
Dr. John Frame, D.o, D.O
Family Medicine — Payments: $8,656
Howard Lafferty, Do, DO
Family Medicine — Payments: $7,233